<?xml version="1.0" encoding="UTF-8"?>
<ref id="B49">
 <mixed-citation publication-type="journal">
  <name>
   <surname>Lawitz</surname>
   <given-names>E</given-names>
  </name>
  <name>
   <surname>Rodriguez-Torres</surname>
   <given-names>M</given-names>
  </name>
  <name>
   <surname>Muir</surname>
   <given-names>AJ</given-names>
  </name>
  <name>
   <surname>Kieffer</surname>
   <given-names>TL</given-names>
  </name>
  <name>
   <surname>McNair</surname>
   <given-names>L</given-names>
  </name>
  <name>
   <surname>Khunvichai</surname>
   <given-names>A</given-names>
  </name>
  <name>
   <surname>McHutchison</surname>
   <given-names>JG</given-names>
  </name>
  <article-title>Antiviral effects and safety of telaprevir, peginterferon alfa-2a, and ribavirin for 28 days in hepatitis C patients</article-title>
  <source>J Hepatol</source>
  <year>2008</year>
  <volume>49</volume>
  <fpage>163</fpage>
  <lpage>169</lpage>
  <pub-id pub-id-type="doi">10.1016/j.jhep.2008.03.027</pub-id>
  <pub-id pub-id-type="pmid">18486984</pub-id>
 </mixed-citation>
</ref>
